{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-038153","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2024-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.262856+00:00","generated_at":"2026-06-04T06:03:09.691151+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Arcadia Q4 revenues up 57% to $1.2M; full-year net loss narrows to $14.0M","bullets":["Q4 2023 product revenue $1.17M (+57% YoY); full-year revenue $5.33M (-28% from $7.42M due to prior-year grain sales and license revenue).","Full-year net loss att. to common stockholders $13.98M ($11.30/share) vs $15.38M ($25.65/share) in 2022, improved by lower operating expenses.","Cash, equivalents, and short-term investments totaled $11.6M at Dec. 31, 2023, down from $20.6M a year earlier; operating cash burn $15.3M.","GoodWheat now in three categories (pasta, pancake/waffle mixes, mac & cheese) and >3,500 stores; Zola coconut water launched pineapple and lime flavors in Q1 2024.","Company initiated strategic review in mid-2023 with Lake Street Capital Markets to explore M&A, sale, or other transactions to maximize GoodWheat value."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-038153","json":"https://secwatch.observer/filing/0000950170-24-038153.json","markdown":"https://secwatch.observer/filing/0000950170-24-038153.md","text":"https://secwatch.observer/filing/0000950170-24-038153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017024038153/0000950170-24-038153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017024038153/rkda-20240328.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T06:03:09.691151+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4feb1ad27f0ae51f48ff21b61e113358c584fc5c","claim":"Arcadia Biosciences, Inc. reported financial results for the fourth quarter and year ended December 31, 2023.","evidence_excerpt":"On March 28, 2024 Arcadia Biosciences, Inc. (the “Company”) issued a press release announcing financial results for the fourth quarter and year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017024038153/0000950170-24-038153-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}